학술논문
Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial
Document Type
Article
Author
Source
In The Lancet Oncology November 2016 17(11):1569-1578
Subject
Language
ISSN
1470-2045